Key facts
- Quant Mid Cap Fund added Adani Energy, Indus Towers, Lenskart Solutions, Persistent Systems, and Torrent Pharmaceuticals in May.
- The fund exited Paytm, SAIL, LIC, and Colgate-Palmolive (India) in May.
- The fund increased its stake in Nippon India Life Asset Management.
- The fund reduced its stake in Premier Energies, Anthem Biosciences, Oracle Financial Services Software, Tata Communications, and Aurobindo Pharma.
- Exposure to Telecom, Power, and Consumer services sectors was increased, while Financial services, Capital goods, and IT sectors saw reduced exposure.
Quant Mid Cap Fund, managed by Sandeep Tandon, has made significant portfolio adjustments in May, adding five new stocks including Adani Energy and Indus Towers, while completely exiting Paytm and three other companies. The fund added 10.67 lakh shares of Adani Energy, valued at Rs 161.50 crore, and also increased its holdings in Indus Towers, Lenskart Solutions, Persistent Systems, and Torrent Pharmaceuticals.
In addition to exiting Paytm, the fund also divested its stakes in SAIL, LIC, and Colgate-Palmolive (India). The fund also saw an increase in its stake in Nippon India Life Asset Management, raising its total holding to 24.89 lakh shares. Conversely, the fund reduced its exposure in Premier Energies, Anthem Biosciences, Oracle Financial Services Software, Tata Communications, and Aurobindo Pharma.
The fund maintained unchanged exposure in approximately 11 stocks, including prominent names like Reliance Industries, ICICI Bank, and Godrej Properties. As of May 31, the portfolio comprised 22 stocks across 17 sectors, with the healthcare sector holding the largest allocation at 15.66%, followed by telecom at 11.64% and iron & steel at 8.16%. The fund's asset allocation was 13.13% in large caps, 57.16% in mid caps, and 7.69% in small caps.
Quant Mid Cap Fund's investment objective is to generate capital appreciation by investing in mid-cap companies with strong growth potential. The fund house noted that mid-caps are entering a favorable phase, supported by improving fundamentals, and the fund aims to deliver superior capital appreciation through disciplined stock selection and active risk management. The fund's performance over the last three months was 12.57%, outperforming its benchmark, Nifty Midcap 150 - TRI, which returned 7.17%.